A Study on the Safety and Effectiveness of the Mantra™ Surgical Robotic System for Soft Tissue Surgeries

NCT06974955 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 365

Last updated 2025-05-16

No results posted yet for this study

Summary

A Real-World, multicentre retrospective study to evaluate the clinical performance and safety of MantraTM Surgical Robotic System for soft tissue surgeries.

The purpose of this retrospective study is to evaluate the clinical performance and safety of the Mantra™ Surgical Robotic System, Model 3.0, for soft tissue surgeries. It aims to provide real-world evidence on the system's reliability, safety, and effectiveness in the real world population. The SSI Mantra 3.0 Surgical Robotic System is an advanced, modular, and cost-effective robotic-assisted surgical platform designed to enhance precision, flexibility, and control in minimally invasive surgeries (MIS).

The objective of this retrospective study is to assess the clinical performance and safety of the Mantra™ Surgical Robotic System in performing various soft tissue surgeries based on retrospective data analysis.

Conditions

  • Soft Tissue Surgeries

Sponsors & Collaborators

  • Clicebo Solutions Private Limited

    collaborator OTHER
  • Sudhir Srivastava Innovations Pvt. Ltd.

    lead INDUSTRY

Principal Investigators

  • Prof. Dr. Somashekhar S P, MBBS, MS, MCh, FRCS, FRCS · Aster CMI Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-31
Primary Completion
2025-08-31
Completion
2025-11-30

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06974955 on ClinicalTrials.gov